Advanced searches left 3/3

Metalloproteinase Inhibitor - Crossref

Summarized by Plex Scholar
Last Updated: 04 May 2022

* If you want to update the article please login/register

Bifunctional inhibitors of urokinase and metalloproteinase-9 for cancer treatment - in silico evaluation

These enzymes are degrading the extracellular matrix that allows for cancer progression and cancer cell mobility. Process of angiogenesis, in which microvascular endothelial cells produce blood vessels, involves local degradation of the underlying basal lamina, which is closely linked to cancer, and it is strongly dependent on MMP-9 and uPA's activity. Malignant tumor proliferation, cancer metastasis, and angiogenesis have all been identified as key contributors to cancer morbidity and mortality among cancer patients, and therefore, therapeutically-directed inhibition can be utilised therapeutically. Numerous in vivo and vitro studies have reported that inhibitory of proteolytic activity may reduce caner invasion, tumor size, and angiogenesis. Consequently, the increased net proteolytic enzyme activity should be normalized rather than trying to block single proteolytic enzyme. MMP-9 and Ki = 1. 36-9 mol for uPA, respectively, had theoretical affinities of Ki = 1. 61-9 mol for MMP-9 and Ki = 1. 36-9 mol for uPA.

Source link: https://doi.org/10.46570/utjms.vol5-2018-243


Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis

TIMP-3 knockout animals develop spontaneous, expanding air space, as we have previously shown. In TIMP-3 null mice, the aim of this research was to determine the effects of a septic lung stress caused by cecal ligation and perfusion on lung function, structure, pulmonary surfactant, and inflammation. When compared to sham wild-type mice, TIMP-3 null rats exposed to sham surgery had a significant rise in lung function. In conclusion, treating TIMP-3 null mice to sepsis rapidly increases these mice's phenotypic abnormalities, thanks to increased MMP activity induced by CLP.

Source link: https://doi.org/10.1152/ajplung.00141.2003


Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma

ProMMP-2 and TIMP-1, but not TIMP-2, were both significantly higher in glioblastomas multiforme in glioblastomas multiforme, according to Analyses' tests using sandwich enzyme immunoassays, but not TIMP-2. In addition, the expression levels and proMMP-2 activation ratio in glioblastomas related to cerebrospinal fluid diffusion were notably higher in glioblastomas associated with cerebrospinal fluid release in glioblastomas associated with cerebrospinal fluid diffusion in glioblastomas associated with cerebrospinal fluid dispersion in glioblastomas associated with cerebrospinal fluid dispersal diffusion in those not associated with CSF infection in gliomos associated with cerebrostan initiation ratio were versus those not involved with cerebros mMP-2 activation in momotin glioblastomos gliogliomomos glioblastoglioglioblastomomospiration similia gliomoblasto gliomos linked with cerebrospinodomm gliomom in gliomos associated with cerebrospinom gliomospinomyr gliomos associated with cerebrospinal In a U251 human glioblastoma cell line, stable transfectants carrying the MT1-MMP gene were developed to investigate these molecules' roles in the invasion of astrocytic tumors more fully. In three-dimensional collagen gel, proMMP-2 and invasive growth were evident; however, mock transfectants and parental cells demonstrated noninvasive growth without activation. According to an imbalance of TIMP-2, these findings indicate that MT1-MMP may contribute to tumor formation and CSF dissemination of glioblastoma cells.

Source link: https://doi.org/10.3171/jns.2001.94.3.0464


Presence of matrix metalloproteinase–2 and tissue inhibitor matrix metalloproteinase–2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas

Object Meningiomas are benign extraaxial tumors with a slow progress. Methods In this research, the researchers examined MMP2 and TIMP2 gene polymorphisms in formalin-fixed paraffin-embedded tissue samples obtained from meningioma patients who had previously undergone surgery at the authors' institution. MMP2 and TIMP2 gene polymorphisms were analyzed from paraffin-embedded tissue sections using the polymerase chain reaction fragment length polymorphism method. MMP2 1306C > T polymorphism showed statistically significant differences between genotype and allele frequencies in patient and control groups. MMP2 1575G > A polymorphism — A polymorphism — was discovered to be more common when brain transplantation was suspected for MMP2 1575G > A polymorphism. Other MMP2 or TIMP2 gene polymorphisms were not statistically significant. Conclusions The authors' findings point to the importance of MMPs and their tissue inhibitors in meningioma pathogenesis.

Source link: https://doi.org/10.3171/2014.8.jns13515


Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients

MMP-9 and tissue inhibitor of metalloproteinase 1 have been described as potential prognostic biomarkers in a variety of clinical settings. MMP-9 and TIMP-1 plasma levels were determined, as well as the MMP-9/TIMP-1 ratio, in predicting the outcome in patients admitted to the intensive care unit. On day 1 and 7 of hospitalization in non-survivors, the incidence of TIMP-1 was statistically significant as compared to survivors. MMP-9 and TIMP-1 showed a statistically significant positive correlation. On day 7 of observation, MMP-9 was highest in the non-survivor group only. In conclusion, although TIMP-1 and MMP-9 levels in non-survivors and the MMP-9/TIMP-1 ratio was higher in patients with some determinants of critical disease, further study is required to determine whether these proteins can be useful biomarkers for early prognostication of ICU patients.

Source link: https://doi.org/10.1515/med-2020-0008


Elevated Urinary Tissue Inhibitor Of Metalloproteinase-2 And Insulin-Like Growth Factor Binding Protein-7 Predict Drug-Induced Acute Kidney Injury

In days leading to AKI development by KDIGO criteria in cases or in non-AKI controls who were matched for age, baseline kidney function, and nephrotoxic exposure, urine creatinine were determined in absolute terms, normalized with urine creatinine. Result: Urinary biomarker analysis was carried out in 21 AKI patients and 28 non-AKI matched-controls; both groups had similar baseline kidney function and duration of nephrotoxic drug therapy; In AKI cases versus controls as early as 2–3 days before AKI's onset, significantly higher absolute, normalized, and composite TIMP2 and IGFBP7 levels were observed; more than 80% of patients with AKIs were found in AKI patients versus controls; more than 70% of patients with corresponding levels above 75% percentile AKI had AKI. After cross-validation, TIMP2 normalized TIMP2 at 2–3 days before AKI predicted AKI with the highest average AUROC of 0. 81, followed by that of composite [TIMP2]x[IGFBP7] after cross-validation.

Source link: https://doi.org/10.2174/1389200223666220425111931


Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9

According to MDA-MB-231 human breast carcinoma cells, kaempferol could reduce adhesion, migration, and invasion of MDA-MB-231 human breast carcinoma cells. Furthermore, kaempferol repressed phorbol-12-myristate-13-acetate-induced MMP-9 development and activity by reducing the translocation of protein kinase C and MAPK signaling pathway, as shown by the figure. In vivo, our findings also showed that kaempferol would prevent B16F10 murine melanoma cells' lung metastasis, as well as the expression of MMP-9. These results, when taken together, showed that kaempferol could inhibit cancer cell invasion by blocking the PKC/AP-1 cascade and subsequent MMP-9 expression and activity. Therefore, kaempferol may be a potential treatment for cancer metastasis.

Source link: https://doi.org/10.1139/bcb-2014-0067


Identification of Novel Natural Product Inhibitors against Matrix Metalloproteinase 9 Using Quantum Mechanical Fragment Molecular Orbital-Based Virtual Screening Methods

Here, we found two effective natural product inhibitors of MMP-9's non-catalytic hemopexin domain using a novel quantum mechanical fragment molecular orbital based virtual screening workflow. We constructed a scoring function with the FMO technique and applied the function to two protein targets from DUD-E benchmark sets in binding affinity estimation. We developed two potent natural product inhibitors for MMP-9's hotspot residues that interact with MMP-9's hotspot residues. Both Laetanine 9 and genkwanin 10 bind to MMP-9 with a dissociation constant of 21. 6 and 0. 614 M, respectively. Overall, we have a tenacious natural product inhibitors of MMP-9, satisfying the pharmacophore model and good bonding affinity, as shown by the pharmacophore model and good bond affinities.

Source link: https://doi.org/10.3390/ijms23084438


Construction of a Microfluidic Platform With Core-Shell CdSSe@ZnS Quantum Dot-Encoded Superparamagnetic Iron Oxide Microspheres for Screening and Locating Matrix Metalloproteinase-2 Inhibitors From Fruits of Rosa roxburghii

CdSSe@ZnS quantum dot encoded superparamagnetic iron oxide microspheres, which served as a carrier for matrix metalloproteinase-2, were produced here by a layer-by-layer assembly process. The matrix metalloproteinase-2 camouflaged magnetic microspheres were expanded into a hand-fabricated microfluidic platform and incubated with extracts of fruits of Rosa roxburghii. Using ellagic acid as a model material, the key influencing variables on ligand binding, including dissociate solvents, incubation pH, ion strength, temperature, and incubation time, were also optimized by using ellagic acid as a model compound. The total recovery of ellagic acid in R. roxburghii's extraction under the optimal extraction conditions ranged from 101. 14 to 102. 4 percent. The screening of thirteen ligands was performed out of R. roxburghii fruit, which had been tested for their inhibitory activity by enzyme assay. Of note, eleven new matrix metalloproteinase-2 inhibitors were discovered, which may account for the anti-tumor formation of fruits of R. roxburghii fruit.

Source link: https://doi.org/10.3389/fnut.2022.869528


Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the Metalloproteinase gelatinase B (MMP-9)

Because neutrophil activation by IL-8 causes the release of gelatinase B, which is involved in the breakdown of extracellular matrix molecules, we hypothesized that MMP-9 release could cause stem cell mobilization by cleaving matrix molecules to which stem cells are attached. Rhesus monkeys were treated with a single i. v. MMP-9 induction was implicated in HPC mobilization, according to a nexious inhibitor monoclonal anti-granulase B antibody. The blocking by the anti-gelatinase B antibody was specific, and pretreatment with an irrelevant control antibody did not have an effect on IL-8-induced mobilization. MMP-9 promotes rapid systemic release of MMP-9, triggering simultaneous mobilization of HPC that is otherwise impossible by pretreatment with an inhibitory anti-gelatinase B antibody, indicating that MMP-9 is acting as a mediator of the IL-8-induced mobilization of HPC.

Source link: https://doi.org/10.1073/pnas.96.19.10863

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions